相关产品推荐更多 >

EZElisa™大鼠金属蛋白酶组织抑制剂4(TIMP4)ELISA试剂盒-EZElisa™ Rat Tissue Inhibitors Of Metalloproteinase 4 (TIMP4) ELISA Kit
询价
EZElisa™人铁螯合酶(FECH)ELISA试剂盒-EZElisa™ Human Ferrochelatase (FECH) ELISA Kit
询价
EZElisa™人DNA-(脱嘌呤或脱嘧啶位点)裂解酶(APE 1/REF 1)ELISA试剂盒-EZElisa™ Human DNA-(apurinic or apyrimidinic site) lyase, (APE1 / REF1) ELISA Kit
询价
EZElisa™犬补体成分5a(C5a)ELISA试剂盒-EZElisa™ Canine Complement Component 5a (C5a) ELISA Kit
询价
EZElisa™小鼠原钙粘蛋白15(PCDH15)ELISA试剂盒-EZElisa™ Mouse Protocadherin 15 (PCDH15) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ Human Endogenous secretory Receptor for Advanced Glycation end Products (esRAGE) ELISA Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™人内源性分泌型晚期糖基化终末产物受体(ESET)ELISA试剂盒,EZElisa™ Human Endogenous secretory Receptor for Advanced Glycation end Products (esRAGE) ELISA Kit,内源性分泌型晚期糖基化终末产物受体(ESET)ELISA试剂盒, Endogenous secretory Receptor for Advanced Glycation end Products (esRAGE) ELISA Kit
产品名称:EZElisa™人内皮细胞特异性分子1(ESM 1)ELISA试剂盒-EZElisa™ Human Endogenous secretory Receptor for Advanced Glycation end Products (esRAGE) ELISA Kit
产品货号:A-QEK03823-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of Endogenous secretory Receptor for Advanced Glycation end Products (esRAGE) in serum and plasma, tissue homogenates and other biological fluids.
种属:Human
检测方法:比色法
检测范围:

该EZElisa™人内源性分泌型晚期糖基化终末产物受体(ESET)ELISA试剂盒ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™人内皮细胞特异性分子1(ESM 1)ELISA试剂盒-EZElisa™ Human Endogenous secretory Receptor for Advanced Glycation end Products (esRAGE) ELISA Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The secretory pathway of the yeast Pichia pastoris has been engineered to produce complex human-type N-glycans (Choi et al., Proc Natl Acad Sci USA 100:5022–5027, 2003; Hamilton et al., Science 301:1244–1246, 2003; Hamilton et al., Science
Site-Specific Chemical Modification of a Glycoprotein Fragment Expressed in Yeast
Site-specific modification of glycoproteins has wide application in both biochemical and biophysical studies. This method describes the conjugation of synthetic molecules to the N-terminus of a glycoprotein fragment, viz., human
Clostridium difficile and the Disease It Causes
vaccine has been developed and human colostrum rich in specific secretory Ig A also support the future use of immunotherapy. Today we experience a tenfold increase of CDI incidence in the western world and both epidemics and therapeutic failure
技术资料暂无技术资料 索取技术资料




